New Anti-Convulsants on the Horizon for Epilepsy Sufferers
Conference on new anti-epileptic drugs highlights 15 new AEDs in the pipeline.
The report on last summer’s European “Eilat” conference was just published in the medical journal Epilepsy Research (2009, volume 83, pages 1-43. It highlights 15 possible new drugs named: Brivaracetam (ucb 34714), Carisbamate (RWJ-333369), 2-Deoxy-D-glucose, Eslicarbazepine Acetate, Ganaxolone, Huperzine A, JZP-4, Lacosamide, NAX-5055, Propylisopropyl Acetamide (PID), Retigabine, T2000, Tonabersat (SB-220453), Valrocemide, and YKP3089.
Some of these drugs are so new that they have numbers instead of names. Others are likely to come into pharmacies within the next year or two, including Brivaracetam, Carisbamate, Eslicarbazepine, Lacosamide and Retigabine.
This list provides considerable hope for those looking for a new AED when trying to control seizures. Many of these drugs work by remarkable mechanisms, different from the older drugs.
Liked it
